An intradermal injection involves administering medication directly into the dermal layer of the skin, located just beneath the epidermis. Because blood supply in the dermis is extremely limited and drug absorption occurs very slowly, this route is rarely used for systemic drug delivery. Instead, primary healthcare providers utilize intradermal routes primarily for diagnostic testing.
Successful delivery requires placing the needle strictly between the epidermal and subcutaneous layers. The preferred sites offer good visibility, minimal hair, and low pigmentation to ensure clear reading of skin reactions.
Using proper equipment ensures accurate dosing and minimizes tissue trauma. The physical characteristics of the needle and syringe are tailored specifically for shallow skin penetration.
| Item | Specification | Purpose |
|---|---|---|
| Syringe | 1 mL tuberculin syringe | Allows precise measurement of tiny liquid volumes |
| Needle Gauge | 25 to 27 gauge | Narrow enough to minimize pain and bleeding |
| Needle Length | 1/4 to 1/2 inch | Short enough to prevent accidental subcutaneous entry |
| Antiseptic | 70% isopropyl alcohol swab | Decontaminates the skin surface before puncture |
Administering an intradermal injection demands steady hands and strict adherence to aseptic technique.
Evaluating skin tests requires precise timing and clinical measurement. For a tuberculin skin test, the patient must return to the clinic within 48 to 72 hours for evaluation.
When assessing the site, the nurse palpates the area to feel for induration—a hard, raised, palpable thickening of the skin—rather than just measuring surface redness or erythema. A transparent ruler is used to measure the diameter of the induration transverse to the long axis of the arm. Documenting only the size of the raised hard area, measured in millimeters, ensures accurate clinical interpretation according to established public health guidelines.
While generally safe, intradermal injections carry risks of local adverse reactions and procedural errors.
Accurate records and clear instructions protect patient safety and ensure continuity of care. Documentation must include the exact medication name, dose, specific anatomical site, date, time, and nurse signature. For diagnostic tests, nurses must record the return appointment date and time for reading results.
Patients receive instructions to keep the injection site uncovered, clean, and dry. They must be warned not to scratch, rub, or apply creams to the bleb. Education also emphasizes the necessity of returning for the follow-up evaluation and reporting any signs of spreading rash, breathing difficulty, or dizziness immediately.